Order: Signal: Tickers:
Filters: 0    Descriptive       Fundamental       Technical       All   
Exchange Index Sector Industry Country
Market Cap. Dividend Yield Float Short Analyst Recom. Option/Short
Earnings Date Average Volume Relative Volume Current Volume Price
 
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 9 #1
TickerAVNW [NASD]
CompanyAviat Networks, Inc.
CountryUSA
IndustryCommunication Equipment
Market Cap93.38MEPS (ttm)-0.72
P/E-EPS this Y-372.20%
Forward P/E31.91EPS next Y138.50%
PEG-EPS past 5Y32.20%
P/S0.28EPS next 5Y12.00%
P/B0.97EPS Q/Q54.50%
Dividend-Sales Q/Q-11.80%
Insider Own0.50%Inst Own69.30%
Insider Trans-1.58%Inst Trans2.48%
Short Float1.78%EarningsJan 29/a
Analyst Recom2.00Target Price2.15
Avg Volume188.45K52W Range0.99 - 2.08
Jan-28-15 10:30AMEricsson Q4 Earnings Miss on Dismal North America Business - Analyst Blog Zacks
Jan-27-15 09:00AMSurvey: IP/MPLS key Technology for Public Safety and Utility Networks PR Newswire
Jan-23-15 09:00AMAviat Networks to Release Fiscal Second Quarter of 2015 Financial Results on January 29, 2015 PR Newswire
Jan-12-15 05:30PMAVIAT NETWORKS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Shareholder Director Nominations, EDGAR Online
Jan-12-15 11:32AMAviat Networks Reaches Agreement with Steel Partners and Lone Star Value Management PR Newswire
Dec-30-14 01:04PMAVIAT NETWORKS, INC. Financials EDGAR Online Financials
Dec-29-14 01:24PMAVIAT NETWORKS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statement EDGAR Online
Dec-24-14 07:07PM10-K for Aviat Networks, Inc. Company Spotlight
Dec-24-14 04:50PMCFO Moves: Aviat Networks, LSB Industries, EasyHotel, LafargeHolcim, ABG Shipyard at The Wall Street Journal
Dec-24-14 09:00AMAviat Networks Announces CFO Transition; Appoints Interim CFO PR Newswire
Aviat Networks, Inc. designs, manufactures, and sells a range of wireless networking products, solutions, and services in North America and Internationally. It offers point-to-point digital microwave transmission systems for first/last mile access, middle mile/backhaul, and long distance trunking applications. The company's products include network management software solutions to enable operators to deploy, monitor, and manage its systems, as well as third party equipment, such as antennas, routers, and multiplexers to build and deploy a wireless transmission network and a suite of turnkey support services. It also provides broadband wireless access base stations and customer premises equipment for fixed and mobile; point-to-point digital microwave radio systems for access, backhaul, trunking, and license-exempt applications; and supporting network deployments, network expansion, and capacity upgrades. In addition, the company offers various professional services, such as network planning and design, site surveys and builds, systems integration, installation, maintenance, network monitoring, training, customer services, and other professional services. It serves wireless/mobile service providers, original equipment manufacturers, distributors, and system integrators; private network users, such as public safety agencies and government institutions; and utility, pipeline, railroad, and other industrial enterprises that operate broadband wireless networks. The company was formerly known as Harris Stratex Networks, Inc. and changed its name to Aviat Networks, Inc. in January 2010. Aviat Networks, Inc. is headquartered in Santa Clara, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stumpe HeinzSVP & Chief Sales OfficerSep 09Sale1.532,4013,674116,980Sep 10 02:18 PM
Elliott Meena L.SVP, Gen. Counsel & SecretarySep 09Sale1.531,5842,42499,632Sep 10 02:19 PM
Madigan JohnVP, Corporate Controller & PAOSep 09Sale1.531,0051,53851,829Sep 10 02:17 PM
Stumpe HeinzSVP & Chief Sales OfficerJun 30Sale1.205,4926,593119,381Jul 01 12:36 PM
Elliott Meena L.SVP, Gen. Counsel & SecretaryJun 30Sale1.202,9063,488101,216Jul 01 12:35 PM
TickerDYAX [NASD]
CompanyDyax Corp.
CountryUSA
IndustryBiotechnology
Market Cap2.20BEPS (ttm)-0.09
P/E-EPS this Y13.30%
Forward P/E-EPS next Y54.50%
PEG-EPS past 5Y24.80%
P/S30.37EPS next 5Y18.60%
P/B20.99EPS Q/Q83.30%
Dividend-Sales Q/Q60.60%
Insider Own0.10%Inst Own97.70%
Insider Trans-66.48%Inst Trans0.04%
Short Float3.50%EarningsFeb 26
Analyst Recom1.60Target Price15.06
Avg Volume1.06M52W Range6.05 - 16.39
Jan-27-15 09:21AMWill Dyax Corp. (DYAX) Continue to Surge Higher? - Tale of the Tape Zacks
Jan-20-15 08:00AMVBL Therapeutics Announces Ron Cohen and Philip Serlin Nominated to Board of Directors GlobeNewswire
Jan-12-15 08:06AMDYAX CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
Dec-10-14 06:17AMCan Dyax (DYAX) Keep the Earnings Streak Alive This Quarter? Zacks
Dec-03-14 07:00AMDyax Corp. to Participate in the 25th Annual Oppenheimer Healthcare Conference Business Wire
Nov-24-14 10:00AMStrong On High Relative Volume: Dyax (DYAX) at TheStreet
Nov-18-14 07:30AMDyax Corp. Recognized as a Top Place to Work by The Boston Globe Business Wire
Nov-07-14 05:50AMWhy Dyax (DYAX) Could Be Positioned for a Surge? Zacks
Nov-05-14 07:08PM10-Q for Dyax Corp. Company Spotlight
Nov-04-14 05:46AMCan Dyax (DYAX) Stock Continue to Grow Earnings? Zacks
Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and plasma kallikrein-mediated (PKM) angioedemas. The company offers KALBITOR for the treatment of acute attacks of HAE. It is developing DX-2930, a human monoclonal antibody inhibitor of plasma kallikrein, which would be a candidate to prophylactically treat HAE and other PKM disorders. The company distributes KALBITOR through a network of wholesale and specialty pharmacy arrangements. It has agreements with CVie Therapeutics for the development and commercialization of KALBITOR in the treatment of HAE and other angioedema indications in China; and Novellus Biopharma AG for the development and commercialization of KALBITOR for the treatment of HAE and other angioedema indications in Latin America, including Argentina, Brazil, Chile, Colombia, Mexico, and Venezuela. The company also has a strategic collaboration agreement with Sigma-Tau Rare Diseases S.A. to develop and commercialize subcutaneous ecallantide for the treatment of HAE and other therapeutic indications in Europe, North Africa, the Middle East, and Russia. Dyax Corp. was founded in 1989 and is headquartered in Burlington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ADELMAN BURT ACMO & EVP, R&DJan 02Option Exercise1.4875,000111,000112,500Jan 05 06:43 PM
ADELMAN BURT ACMO & EVP, R&DJan 02Sale14.0575,0001,053,86337,500Jan 05 06:43 PM
KEMPNER THOMAS LDirectorNov 21Sale13.20100,0001,319,910617,120Nov 24 04:26 PM
MCLACHLAN DAVID JDirectorNov 20Option Exercise3.8213,00049,66042,100Nov 24 04:15 PM
MCLACHLAN DAVID JDirectorNov 20Sale13.1113,000170,46929,100Nov 24 04:15 PM
TickerKOS [NYSE]
CompanyKosmos Energy Ltd.
CountryBermuda
IndustryIndependent Oil & Gas
Market Cap3.46BEPS (ttm)0.40
P/E22.37EPS this Y-33.30%
Forward P/E-EPS next Y-134.40%
PEG0.98EPS past 5Y-4.80%
P/S3.86EPS next 5Y22.85%
P/B2.86EPS Q/Q141.70%
Dividend-Sales Q/Q-35.70%
Insider Own0.50%Inst Own86.90%
Insider Trans-95.98%Inst Trans-2.23%
Short Float2.64%EarningsFeb 23/b
Analyst Recom2.50Target Price12.13
Avg Volume1.83M52W Range6.96 - 11.34
Jan-26-15 07:00AMKosmos Energy to Host Fourth Quarter and Full Year 2014 Results Conference Call and Webcast on February 23, 2015 Business Wire
Nov-21-14 10:01AMTrade-Ideas: Kosmos Energy (KOS) Is Today's Strong On High Relative Volume Stock at TheStreet
Nov-14-14 01:04PMKOSMOS ENERGY LTD. Financials EDGAR Online Financials
Nov-07-14 06:30AMKosmos Energy upgraded by RBC Capital Mkts Briefing.com
Nov-03-14 11:00AMKosmos Energy Ltd Earnings Call scheduled for 11:00 am ET today CCBN
Nov-03-14 07:09AMKosmos Energy misses 3Q profit forecasts AP
Nov-03-14 07:07AMQ3 2014 Kosmos Energy Ltd Earnings Release - Before Market Open CCBN
Nov-03-14 07:00AMKosmos Energy Announces Third Quarter 2014 Results Business Wire
Nov-03-14 06:59AMKOSMOS ENERGY LTD. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Finan EDGAR Online
Oct-27-14 10:00AMWarburg Pincus Completes $4 Billion Global Private Equity Energy Fundraise PR Newswire
Kosmos Energy Ltd. explores and produces oil and gas in Africa, Europe, and South America. Its asset portfolio includes production and other projects offshore Ghana, as well as exploration licenses with hydrocarbon potential offshore Ireland, Mauritania, Morocco, and Suriname. The company was founded in 2003 and is based in Hamilton, Bermuda.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BCP IV GP L.L.C.10% OwnerOct 10Sale9.336,749,99562,977,453270,001Oct 10 05:36 PM
Blackstone Holdings III L.P.10% OwnerOct 10Sale9.336,750,00062,977,500270,001Oct 10 05:35 PM
WARBURG PINCUS & CO.DirectorOct 10Sale9.337,951,43774,186,90756,556,832Oct 15 01:50 PM
WARBURG PINCUS & CO.DirectorOct 10Sale9.3316,500,000153,945,000118,008,651Oct 15 01:50 PM
Krieger David BenjaminDirectorOct 10Sale9.338,250,00076,972,500118,008,651Oct 15 01:54 PM
TickerMHLD [NASD]
CompanyMaiden Holdings, Ltd.
CountryBermuda
IndustryProperty & Casualty Insurance
Market Cap939.45MEPS (ttm)0.89
P/E14.48EPS this Y79.70%
Forward P/E7.11EPS next Y21.84%
PEG1.21EPS past 5Y29.20%
P/S0.42EPS next 5Y12.00%
P/B1.05EPS Q/Q20.00%
Dividend4.04%Sales Q/Q16.70%
Insider Own5.00%Inst Own71.60%
Insider Trans0.00%Inst Trans-0.03%
Short Float6.28%EarningsFeb 17/a
Analyst Recom1.50Target Price15.50
Avg Volume376.53K52W Range10.26 - 13.52
Dec-19-14 09:56AMAlistair Capital Delivers Letter to AmTrust Financial Services, Inc.'s Audit Committee PR Newswire
Nov-21-14 01:04PMMAIDEN HOLDINGS, LTD. Financials EDGAR Online Financials
Nov-17-14 04:24PMMAIDEN HOLDINGS, LTD. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
Nov-13-14 03:41PMMaiden Holdings (MHLD) & CNB Financial (CCNE): This Week's Growth & Income Stocks Zacks
Nov-13-14 05:49AMWhy Maiden Holdings (MHLD) Could Be a Top Value Stock Pick Zacks
Nov-12-14 07:09PM10-Q for Maiden Holdings Ltd. Company Spotlight
Nov-10-14 05:18PMMAIDEN HOLDINGS, LTD. Files SEC form 10-Q, Quarterly Report EDGAR Online
Nov-07-14 02:13PMMaiden Holdings (MHLD) Shares Rise on Dividend Increase Zacks
Nov-06-14 06:07AMMAIDEN HOLDINGS, LTD. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
Nov-05-14 07:46PMMaiden Holdings posts 3Q profit AP
Maiden Holdings, Ltd., together with its subsidiaries, provides reinsurance solutions to regional and specialty insurers in the United States, Europe, and internationally. The company operates through three segments: Diversified Reinsurance, AmTrust Quota Share Reinsurance, and NGHC Quota Share. The Diversified Reinsurance segment offers property, casualty, accident, and health reinsurance products through the treaties with other insurers on a quota share or excess of loss basis, as well as on a facultative basis primarily through third-party intermediaries and on a direct basis. The AmTrust Quota Share Reinsurance segment provides small commercial business insurance, which includes workers' compensation, commercial package, and other property and casualty insurance products; specialty risk and extended warranty coverage for consumer and commercial goods, as well as custom designed coverage, including accidental damage plans and payment protection plans in connection with the sale of consumer and commercial goods; and specialty program that comprises package products, general liability, commercial auto liability, excess and surplus lines programs, and other specialty commercial property and casualty insurance to small and middle market companies. The NGHC Quota Share segment reinsures personal lines automobile business under the quota share reinsurance agreement. The company also offers credit life reinsurance. The company was founded in 2007 and is headquartered in Hamilton, Bermuda.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SCHMITT KARENChief Financial OfficerSep 03Option Exercise4.0024,17596,610111,324Sep 03 04:03 PM
NEFF RAYMOND MICHAELDirectorMar 27Option Exercise0.0024,0000249,000Mar 28 06:55 AM
MARSHALECK JOHNCHIEF FINANCIAL OFFICERMar 21Option Exercise3.2825,00082,00079,730Mar 24 05:04 PM
RASCHBAUM ARTURO MANUELPRESIDENT AND CEOFeb 18Option Exercise0.00136,6050270,892Feb 20 04:20 PM
TickerMR [NYSE]
CompanyMindray Medical International Limited
CountryChina
IndustryMedical Instruments & Supplies
Market Cap3.24BEPS (ttm)1.84
P/E14.99EPS this Y24.70%
Forward P/E13.91EPS next Y9.61%
PEG-EPS past 5Y14.30%
P/S2.50EPS next 5Y-0.90%
P/B2.11EPS Q/Q56.00%
Dividend1.81%Sales Q/Q9.60%
Insider Own1.93%Inst Own-
Insider Trans0.00%Inst Trans0.95%
Short Float15.75%EarningsMar 02/a
Analyst Recom2.60Target Price32.05
Avg Volume723.25K52W Range25.90 - 36.03
Jan-22-15 07:00AMMindray Medical International Limited (MR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Zacks
Jan-16-15 09:30AMThe Zacks Analyst Blog Highlights: Bitauto Holdings, JD.com, Alibaba Group Holding, Citigroup and Mindray Medical International - Press Releases Zacks
Jan-15-15 02:36PMChina Stock Roundup: JD, Tencent to Invest $1.55B in Bitauto, Alibaba Pays $575M for Stake in One97 - Analyst Blog Zacks
Jan-12-15 06:55AMMindray Announces Preliminary 2014 Operating Results and 2015 Net Revenues Guidance PR Newswire
Jan-06-15 08:00AMMindray to Participate in Upcoming Investor Conferences and Events PR Newswire
Dec-12-14 05:00PMMindray Announced Shareholder Resolutions Post 2014 Annual General Meeting PR Newswire
Nov-24-14 07:30AMAmerican Biotech Start-Ups Head To China For Capital Partners at Forbes
Nov-13-14 06:00AMMindray to Hold Annual General Meeting in Hong Kong on December 10, 2014 PR Newswire
Nov-04-14 02:10PMMindray Medical Q3 Earnings in Line, 2014 View Lowered Zacks
Nov-04-14 08:00AMMindray Medical International Ltd Earnings Call scheduled for 8:00 am ET today CCBN
Mindray Medical International Limited develops, manufactures, and markets medical devices worldwide. The company operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. The Patient Monitoring and Life Support Products segment offers monitoring devices that track the physiological parameters of patients, such as heart rate, blood pressure, respiration, and temperature. Its products include single and multiple-parameter monitors; mobile and portable multifunction monitors; central stations that can collect and display multiple patient data on a single screen; electro-cardiogram monitoring devices; and veterinary monitoring devices. This segment also provides anesthesia machines; defibrillators; surgical equipment, including surgical beds, and surgical lights ceiling pendants; syringes and infusion pumps; and ventilators. The In-Vitro Diagnostic Products segment provides data and analysis on blood, urine, and other bodily fluid samples for clinical diagnosis and treatment; and in-vitro diagnostic products for laboratories, clinics, and hospitals to perform analysis to detect and quantify substances in patient samples. Its product portfolio consists of hematology analysis products, biochemistry analysis products, immunoassay products, coagulation analysis products, urine sediment analysis products, and microbiology analysis products; and reagents used in in-vitro diagnostic products. The Medical Imaging Systems segment offers ultrasound systems used in medical fields, such as urology, gynecology, obstetrics, and cardiology; digital radiography systems; and magnetic resonance imaging systems. The company also provides orthopedic products, endoscope devices, and healthcare IT solutions. Its markets and sells its products through distributors, as well as directly to hospitals and government agencies. The company was founded in 1991 and is headquartered in Shenzhen, The People's Republic of China.
TickerRJET [NASD]
CompanyRepublic Airways Holdings Inc.
CountryUSA
IndustryRegional Airlines
Market Cap717.33MEPS (ttm)1.32
P/E10.92EPS this Y46.00%
Forward P/E9.78EPS next Y8.54%
PEG0.48EPS past 5Y-17.60%
P/S0.52EPS next 5Y22.71%
P/B1.19EPS Q/Q288.90%
Dividend-Sales Q/Q3.30%
Insider Own1.50%Inst Own86.20%
Insider Trans-24.04%Inst Trans0.42%
Short Float1.93%EarningsFeb 25/a
Analyst Recom2.50Target Price15.00
Avg Volume498.39K52W Range7.82 - 14.99
Jan-22-15 06:32PMNew Highs: Income Stocks Dominate; TSM Breaks Out at Investor's Business Daily
Jan-22-15 06:32PMAirlines Stocks Take Flight As Fuel Prices Fall at Investor's Business Daily
Jan-20-15 05:50PMTop Airline Stocks: Republic Air Up On Delta Report at Investor's Business Daily
Jan-15-15 05:33PMAirline Leaders Alaska Air, Republic Cruising at Investor's Business Daily
Jan-08-15 06:00AMRepublic Airways Holdings reports December 2014 traffic Business Wire
Jan-02-15 05:45PMFour Top Airline Stocks Soar As Oil Prices Plunge at Investor's Business Daily
Dec-31-14 11:58AMStocks Bounce Back; Airlines Lead As Oil Falls at Investor's Business Daily
Dec-30-14 05:44PM5 Stock Industries Benefiting From Lower Oil Prices at Investor's Business Daily
Dec-18-14 06:42PMFalling Oil Prices Help Airlines, Truckers at Investor's Business Daily
Dec-12-14 04:49PMREPUBLIC AIRWAYS HOLDINGS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an EDGAR Online
Republic Airways Holdings Inc., through its subsidiaries, provides scheduled passenger services. It offers scheduled passenger service on approximately 1,390 flights daily to approximately 118 cities in the U.S. and Canada through fixed-fee flights operated under airline partner brands, including American Eagle, Delta Connection, United Express, and US Airways Express. As of December 31, 2013, the company operated a combined fleet of approximately 258 aircraft. It is also engaged in charter and cargo operations. The company was founded in 1996 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Arnell Lars ErikSVP Corporate DevelopmentJan 22Option Exercise10.292,50025,72557,500Jan 26 04:51 PM
Dooley Timothy P.EVP, CFO, Treasurer, SecretaryJan 22Option Exercise12.7038,490488,82398,490Jan 26 04:53 PM
Arnell Lars ErikSVP Corporate DevelopmentJan 22Sale14.892,50037,22555,000Jan 26 04:51 PM
Dooley Timothy P.EVP, CFO, Treasurer, SecretaryJan 22Sale14.7738,490568,49760,000Jan 26 04:53 PM
Dooley Timothy P.EVP, CFO, Treasurer, SecretaryJan 05Option Exercise12.703003,81060,300Jan 05 05:20 PM
TickerSGMO [NASD]
CompanySangamo Biosciences Inc.
CountryUSA
IndustryBiotechnology
Market Cap943.24MEPS (ttm)-0.46
P/E-EPS this Y-14.30%
Forward P/E-EPS next Y-12.20%
PEG-EPS past 5Y4.40%
P/S24.95EPS next 5Y-
P/B4.48EPS Q/Q0.00%
Dividend-Sales Q/Q117.50%
Insider Own1.50%Inst Own77.40%
Insider Trans-29.37%Inst Trans1.77%
Short Float13.87%EarningsFeb 09/a
Analyst Recom1.60Target Price25.60
Avg Volume878.95K52W Range9.39 - 24.69
Jan-12-15 07:00AMSangamo BioSciences To Highlight 2015 Catalysts And Advancement Of ZFP Therapeutic Programs At The 33rd Annual J.P. Morgan Healthcare Conference PR Newswire
Jan-09-15 11:57AMHow to play the JPMorgan health conference at CNBC
Jan-08-15 07:00AMSangamo BioSciences Announces In-Licensing Of mRNA Delivery Technology And Expansion Of Therapeutic Pipeline Opportunities For Sangamo's In Vivo ZFN Genome-Editing Platform PR Newswire
Jan-05-15 04:15PMSangamo BioSciences Announces Presentation At The 33rd Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-18-14 09:35AM2014 Healthcare Stock Report Card: Sobek Tracks His Hits and Misses at TheStreet
Dec-17-14 03:56PMIs Sangamo The Next Biotech Stock To Break Out? Benzinga
Dec-12-14 07:31AMSangamo Biosciences (SGMO) Jumps: Stock Rises 7.2% Zacks
Dec-08-14 07:00AMSangamo BioSciences Presents New Data at American Society of Hematology Meeting Demonstrating Broad Application of ZFN Mediated Genome-Editing Approach to Therapeutics for Hemophilia and Lysosomal Storage Disorders PR Newswire
Nov-19-14 07:00AMSangamo BioSciences Presents Study At Society For Neuroscience Meeting Demonstrating In Vivo Reversal Of Huntington's Disease Signs And Symptoms PR Newswire
Nov-18-14 04:02PMSangamo BioSciences Announces Presentation at the 26th Annual Piper Jaffray Healthcare Conference GlobeNewswire
Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of zinc finger DNA-binding proteins (ZFPs) for gene regulation and gene modification in the United States. Its ZFPs could be engineered to make ZFP nucleases (ZFNs) proteins, which could be used to modify DNA sequences in various ways; and ZFP transcription factors (ZFP TFs) proteins could be used to turn genes on or off. The company's principal ZFP therapeutic is SB-728-T, a ZFN-modified autologous T-cell product, which is in Phase II and Phase I/II clinical trials for the treatment of human immunodeficiency virus and acquired immunodeficiency syndrome. It also develops CERE-110 that is in Phase II clinical trial for the treatment of Alzheimer's disease. In addition, the company has ZFP therapeutic pre-clinical stage programs for hemophilia A and B, huntington's disease, and hemoglobinopathies; and proprietary programs in the areas of lysosomal storage disorders. Further, it has ZFP therapeutic research stage programs in the areas of other monogenic diseases, including various immunodeficiencies, as well as central nervous system disorders and cancer immunotherapy. The company has collaboration and license agreements with Shire International GmbH and Biogen Idec Inc.; and strategic partnerships with Sigma-Aldrich Corporation, Dow AgroSciences, LLC, Open Monoclonal Technology, Inc., F. Hoffmann-La Roche Ltd, and Hoffmann-La Roche Inc. Sangamo Biosciences, Inc. was founded in 1995 and is headquartered in Richmond, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LANPHIER EDWARD O IIPresident & CEOJan 16Sale14.2910,000142,853235,000Jan 16 08:20 PM
LANPHIER EDWARD O IIPresident & CEOJan 15Option Exercise6.8215,000102,300250,000Jan 16 08:20 PM
LANPHIER EDWARD O IIPresident & CEOJan 15Sale14.1815,000212,769235,000Jan 16 08:20 PM
Wolff Henry WardExec VP & CFOJan 12Option Exercise3.4510,00034,500220,849Jan 14 07:02 PM
Wolff Henry WardExec VP & CFOJan 12Sale15.8712,000190,450208,849Jan 14 07:02 PM
TickerSOL [NYSE]
CompanyReneSola Ltd.
CountryChina
IndustrySemiconductor - Specialized
Market Cap142.52MEPS (ttm)-0.24
P/E-EPS this Y-1.10%
Forward P/E46.67EPS next Y107.90%
PEG-EPS past 5Y-27.00%
P/S0.09EPS next 5Y15.00%
P/B0.97EPS Q/Q94.60%
Dividend-Sales Q/Q-11.20%
Insider Own45.67%Inst Own15.80%
Insider Trans0.00%Inst Trans8.68%
Short Float10.35%EarningsNov 26/b
Analyst Recom3.50Target Price1.88
Avg Volume1.24M52W Range1.20 - 4.37
Jan-28-15 05:15AMSasol Announces Plan to Respond to the Low Oil Price Environment PR Newswire
Dec-22-14 10:06AMSasol Announces Completion of US$4 Billion Credit Facility for its World-Scale Ethane Cracker and Derivatives Complex in Louisiana PR Newswire
Dec-12-14 08:52AMS.Africa's ANC eyes state sell-off to ease power crunch Reuters
Dec-03-14 04:00PMReneSola (SOL) Ramps up its Operations in North America Zacks
Dec-03-14 06:50AMReneSola Expands into Canada CNW Group
Dec-02-14 05:00AMReneSola Expands North American Operations PR Newswire
Nov-27-14 08:10AMReneSola Incurs Q3 Loss, Cuts Module Shipment Guidance Zacks
Nov-26-14 08:00AMReneSola Ltd Earnings Call scheduled for 8:00 am ET today CCBN
Nov-26-14 07:07AMQ3 2014 ReneSola Ltd Earnings Release - Before Market Open CCBN
Nov-26-14 06:32AMReneSola revenue falls on lower shipments Reuters
ReneSola Ltd, through its subsidiaries, manufactures and sells various solar power products. It operates through two segments, Wafer, and Cell and Module. The company offers virgin polysilicon; mono crystalline and multi crystalline solar wafers; and photovoltaic cells. It also provides mono crystalline and multi crystalline solar modules for use in various residential, commercial, industrial, and other solar power generation systems. In addition, the company offers wafer processing services. It offers its products to the manufacturers of solar cells and modules, distributors, installers, and end users of solar modules. The company operates in Mainland China, Taiwan, Australia, Singapore, Korea, India, Hong Kong, Japan, Germany, Greece, Belgium, Italy, France, the United States, Spain, Czech Republic, England, the Netherlands, and South Africa. ReneSola Ltd was founded in 2005 and is based in Jiashan, the People's Republic of China.
TickerSPWR [NASD]
CompanySunPower Corporation
CountryUSA
IndustrySemiconductor - Specialized
Market Cap3.33BEPS (ttm)0.86
P/E29.50EPS this Y122.90%
Forward P/E18.57EPS next Y3.80%
PEG12.29EPS past 5Y19.60%
P/S1.33EPS next 5Y2.40%
P/B2.40EPS Q/Q-72.60%
Dividend-Sales Q/Q0.90%
Insider Own0.30%Inst Own38.50%
Insider Trans-46.88%Inst Trans-0.59%
Short Float20.13%EarningsFeb 24/b
Analyst Recom2.00Target Price38.73
Avg Volume2.41M52W Range22.75 - 42.07
Jan-23-15 08:00AMTotal and SunPower Celebrate Completion of 70-megawatt PV Salvador Solar Plant in Chile PR Newswire
Jan-21-15 04:05PMSunPower to Announce Fourth-Quarter, Year-End 2014 Results on Feb. 24, 2015 PR Newswire
Jan-20-15 06:09PMSunEdison Inc. (SUNE) Raises Capital to Fund Acquisition - Analyst Blog Zacks
Jan-18-15 11:29AMThe End of the Partisan Divide Over Climate Change at Forbes
Jan-15-15 04:20PMSolarCity to Launch $200M Financing Facility under MyPower - Analyst Blog Zacks
Jan-14-15 04:30PMTOTAL Invests in Stem to Support Energy Efficiency Projects - Analyst Blog Zacks
Jan-13-15 06:00PMCramer: Ecstasy & agony in one session CNBC
Jan-13-15 12:13PM4 Stocks, 4 trades: Amazon higher on upgrade, Woody Allen CNBC
Jan-13-15 12:11PMStocks Up Over 1% At Midday; Lennar's Breakout Fades at Investor's Business Daily
Jan-13-15 09:20AMSunPower (SPWR) Stock Up in Pre-Market Trading Today After Ratings Upgrade at TheStreet
SunPower Corporation, an energy services company, designs, manufactures, and delivers solar systems to residential, commercial, and utility customers. It operates in three segments: the Americas, the EMEA, and the APAC. The company offers solar power products, including panels, balance of system components, and inverters. It also designs, manufactures, and sells high-performance rooftop and ground-mounted solar power systems, as well as utility-scale photovoltaic power plants. In addition, the company offers operations and maintenance services, including remote monitoring, preventative, and corrective maintenance services, as well as rapid-response outage restoration and inverter repair services. Further, it leases solar power systems to residential customers. The company serves investors, financial institutions, project developers, electric utilities, independent power producers, commercial and governmental entities, production home builders, residential owners, and small commercial building owners. SunPower Corporation was incorporated in 1985 and is headquartered in San Jose, California. SunPower Corporation is a subsidiary of Total Energies Nouvelles Activits USA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WERNER THOMAS HDirector, Pres and CEODec 02Sale25.8525,000646,285182,934Dec 04 05:35 PM
MCDANIEL THOMAS RDirectorNov 11Option Exercise0.002,55302,669Nov 13 07:49 PM
Wood Patrick IIIDirectorNov 11Option Exercise0.002,553026,919Nov 13 07:35 PM
LESJAK CATHERINE ADirectorNov 11Option Exercise0.002,55304,675Nov 13 07:42 PM
Richards Douglas J.EVP, AdministrationNov 10Sale30.221,09533,0918,395Nov 12 05:07 PM
1